Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression

Targeting at enhancing reverse cholesterol transport (RCT) is apromising strategy for treating atherosclerosis via infusion of reconstitute high density lipoprotein (HDL) as cholesterol acceptors or increase of cholesterol efflux by activation of macrophage liver X receptors (LXRs). However, systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yanhong, Yuan, Wenmin, Yu, Bilian, Kuai, Rui, Hu, Wenting, Morin, Emily E., Garcia-Barrio, Minerva T., Zhang, Jifeng, Moon, James J., Schwendeman, Anna, Eugene Chen, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835545/
https://www.ncbi.nlm.nih.gov/pubmed/29361501
http://dx.doi.org/10.1016/j.ebiom.2017.12.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835545/
https://www.ncbi.nlm.nih.gov/pubmed/29361501
http://dx.doi.org/10.1016/j.ebiom.2017.12.021

Ejemplares similares